DECHRA VETERINARY PRODUCTS A/S: Financial statements 2024
CVR: 10114241
DECHRA VETERINARY PRODUCTS A/S (CVR 10114241) has filed annual accounts for 2024. In 2024, the company reported revenue of DKK 2,680,690,000 and a net result of DKK 116,939,000 compared with DKK 129,704,000 the year before. That is an increase of 6.7% compared with the year before. The profit margin was 4.4%. Equity amounted to DKK 631,669,000. The solvency ratio was 45.6%. The company had 108 employees in the financial year.
- Revenue
- 2,680,690,000 kr.
- Gross Profit
- 240,932,000 kr.
- Profit/Loss
- 116,939,000 kr.
- Equity
- 631,669,000 kr.
- Total Assets
- 1,386,097,000 kr.
- Employees
- 108
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | 2.7 mia. | 240.9 mio. | 116.9 mio. | 631.7 mio. | 108 |
| 2023 | 2.5 mia. | 238.9 mio. | 129.7 mio. | 688.9 mio. | 110 |
| 2022 | 2.4 mia. | 255.8 mio. | 157.6 mio. | 560.4 mio. | 108 |
| 2021 | 2.1 mia. | 192.2 mio. | 98.3 mio. | 403.1 mio. | 98 |
| 2020 | 1.6 mia. | 112 mio. | 23.3 mio. | 302.8 mio. | 91 |
How creditworthy is DECHRA VETERINARY PRODUCTS A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2024
As of June 10, 2024, Milton McCann has joined the board of directors of DECHRA VETERINARY PRODUCTS A/S.
As of June 10, 2024, Ian David Page has left the board of directors of DECHRA VETERINARY PRODUCTS A/S.
As of June 10, 2024, Milton McCann is registered as director of DECHRA VETERINARY PRODUCTS A/S.
As of June 10, 2024, Ian David Page has stepped down as director of DECHRA VETERINARY PRODUCTS A/S.
About DECHRA VETERINARY PRODUCTS A/S
DECHRA VETERINARY PRODUCTS A/S is a Danish company of the type Aktieselskab based in Uldum, founded in 1986. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named VETXX A/S and LEO ANIMAL HEALTH A/S. The management consists of Ian Machan Mackellar. The company is owned by Dechra Pharmaceuticals Limited. The company has 78 employees. In 2025, the company reported revenue of DKK 2,875,016,000 and a net result of DKK 189,967,000 compared with DKK 116,939,000 the year before. Equity amounted to DKK 571,636,000.
